Benzene and Leukemia

References

• Adler, I.D. and Kliesch, U., Comparison of single and multiple treatment regimens in the mouse bone marrow micronucleus assay for hydro- quinone (HQ) and cyclophosphamide (CP). Mut. Res. 234, 115–123, 1990.
   PubMedGoogle Scholar
• Ahmad, S. and Rao, G.S., Complexation of 1,2,4– benzenetriol with inorganic and ferritin-re- leased iron. Biochem. Biophys. Res. Commun. 27, 169–171, 1999.
   Google Scholar
• Ahmad, S., Singh, V., and Rao, G.S., Release of iron from ferritin by 1,2,4–benzenetriol. Chem. Biol. Interactions. 96, 103–111, 1995.
   PubMedGoogle Scholar
• Aksoy, M., Benzene hematotoxicity, in Benzene Hematotoxicity. Aksoy, M., Ed., CRC Press, 1988, 104–112.
   Google Scholar
• Aksoy, M., Hematotoxicity, leukemogenicity and carcinogenicity of chronic exposure to ben- zene, in Molecular Aspects of Monooxygenases and Bioactivation of Toxic Compounds. Arinç, E., Schenkman, J.B. and Hodgson, E., Eds., NATO ASI Series, and NATO Scientific Af- fairs Division, Plenum Press, New York, 1991. 425–434.
   Google Scholar
• Aksoy, M., Dinçol, K., Akgün, T., Erdem, S., and Dinçol. G. Haematological effects of chronic benzene poisoning in 217 workers. Br. J. Ind. Med. 28, 296–302, 1971.
   PubMedGoogle Scholar
• Aksoy, M., Dinçol, K., Erdem, S., Akgün, T., and Dinçol. G., Details of blood changes in 32 patients with pancytopenia associated with long-term exposure to benzene. Brit. J. Ind. Med. 29, 56–64, 1972.
   PubMedGoogle Scholar
• Andrews, L.S., Lee, E.W., Witmer, C.M., Kocsis, J.J., and Snyder, R., Effects of toluene on the metabolism, disposition and hematopoi- etic toxicity of benzene. Biochem. Pharmacol. 26, 293–300, 1977.
   PubMed Web of Science ®Google Scholar
• Andrews, L.S., Sasame, H.A., and Gillette, J.R., 3H-benzene metabolism in rabbit bone mar- row. Life Sci. 25, 567– 572, 1979.
   PubMed Web of Science ®Google Scholar
• Antunes, F. and Cadenas, E., Cellular titration of apoptosis with steady state concentra- tions of H2O2: Submicromolar levels of H2O2 induce apoptosis through fenton chemistry indepdendent of the cellular thiol state. Free Radic. Biol. Med. 30, 1008– 1018, 2001.
   PubMed Web of Science ®Google Scholar
• Arfellini, G., Grilli, S., Colacci, A., Mazzullo, M., and Prodi, G., In vivo and in vitro binding of benzene to nucleic acids and proteins of vari- ous rat and mouse organs. Cancer Lett. 15, 159– 168, 1985.
   Google Scholar
• Austin, H., Delzell, E., and Cole, P., Benzene and leukemia. A review of the literature and a risk assessment. Am. J. Epidemiol. 127, 419–4391988.,
   Google Scholar
• Ayoma, K., Effects of benzene inhalation on lym- phocyte subpopulations and immune response in mice. Toxicol. Appl. Pharmacol.85, 92– 101, 1986.
   PubMedGoogle Scholar
• Barbicid, M., Ras genes. An. Rev. Biochem. 56, 779–827, 1987.
   PubMedGoogle Scholar
• Bakke, O.M. and Scheline, R.R., Hydroxylation of aromatic hydrocarbons in the rat. Toxicol. Appl. Pharmacol. 16, 691–700, 1970.
   PubMed Web of Science ®Google Scholar
• Bechtold, W.E., Sun. J.D., Birnbaum, L.S., Yin,
   Google Scholar
• S.N., Li, G.L., Kasicki, S., Lucier, G., and Henderson, R.F., S-Phenylcysteine forma- tion in hemoglobin as a biological exposure index to benzene. Arch. Toxicol. 66, 303– 309, 1992b.
   PubMedGoogle Scholar
• Bechtold, W.E., Willis, J.K., Sun, J.D., Griffith, W.C., and Reddy, T.V., Biological markers of exposure to benzene: S-phenylcysteine in albumin. Carcinogenesis 13, 1217–1220, 1992a.
   PubMed Web of Science ®Google Scholar
• Bhat, R.V., Subrahmanyam, V.V., Sadler, A., and Ross, D., Bioactivation of catechol in rat and human bone marrow cells. Toxicol. Appl. Pharmacol. 94, 297–304, 1988.
   PubMed Web of Science ®Google Scholar
• Boatman, R.J., English, J.C., Perry, L.G., and Fiorica, L.A., Covalent protein adducts of hydroquinone in tissues from rats: identifica- tion and quantitation of sulfhydryl-bound forms. Chem. Res. Toxicol. 13, 853–860, 2000.
   PubMedGoogle Scholar
• Bodell, W.J., Levay, G., and Pongracz K., Inves- tigation of DNA benzene-DNA adducts and their detection in human bone marrow. Environ. Health Perspect. 99, 241–244, 1993.
   PubMed Web of Science ®Google Scholar
• Bodell, W.J., Pathak, D.N., Levay, G., Ye, Q., and Pongracz, K., Investigation of the DNA adducts formed in B6C3F1 mice treated with benzene: implications for molecular dosim- etry. Environ. Health Perspect. 104 (Suppl 6), 1189–1193, 1996.
   Google Scholar
• Bolcsak, L.E. and Nerland, D.E., Inhibition of erythropoiesis by benzene and benzene me- tabolites. Toxicol. Appl. Pharmacol. 69, 363–368,1983.
   Google Scholar
• Bonassi, S., Abbondandolo, A., Camurri, L., Dal Pra, L., De Ferrari, M., Degrassi, F., Forni, A., Lamberti, L., Lando, C., Padovani, P., Sbrana, I., Vecchio, D., and Puntoni, R. Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet. Cytogenet., 79, 133– 135, 1995.
   PubMed Web of Science ®Google Scholar
• Bos, J.L., Ras oncogenes in human cancer: a re- view. Cancer Res. 49, 4682–4689, 1989.
   PubMed Web of Science ®Google Scholar
• Bratton, S.B., Lau, S.S., and Monks T.J., Identi- fication of quinol thioethers in bone marrow of hydroquinone/phenol-treated rats and mice and their potential role in benzene-mediated hematotoxicity. Chem. Res. Toxicol. 10, 859–865, 1997.
   PubMed Web of Science ®Google Scholar
• Bratton, S.B., Lau, S.S., and Monks T.J., The putative benzene metabolite 2,3,5–tris (glutathion-S- yl)hydroquinone depletes glu- tathione, stimulates sphingomyelin turnover, and induces apoptosis in HL-60 cells. Chem. Res. Toxicol. 13, 550–556, 2000.
   PubMed Web of Science ®Google Scholar
• Brookes, P., Role of covalent binding in carcinoge- nicity, In Biological Reactive Intermediates I: formation, toxicity, and inactivation. Jollow, D.J., Kocsis, J.J., Snyder, R., and Vainio, H., Eds., Plenum Press, New York, 1977, 470–480.
   Google Scholar
• Buckton, K.E. and Pike, M.C., Time in culture: an important variable in studying in vivo radiation- induced chromosome damage in man. Int. J. Rad. Biol. 8, 439–452, 1964.
   Web of Science ®Google Scholar
• Busby, W.F., Jr, Wang, J., Stevens, E.K., Padykula, R.E., Alekejczyk, R.A., and Berchtold, G.A., Lung tumorigenicity of benzene oxide, benzene dihydrodiols, and benzene diolepoxides in the BLU:Ha new- born mouse assay. Carcinogenesis 11, 1473–1478, 1990.
   Google Scholar
• Camp, W.E. and Baumgartner, E.A., Inflamma- tory reactions in rabbits with a severe leu- copenia. J. Exp. Med. 22, 174–194, 1915.
   PubMedGoogle Scholar
• Chen, H. and Eastmond, D.A., Topoisomerase inhibition by phenolic metabolites: a poten- tial mechanism for benzene’s clastogenic ef- fects. Carcinogenesis 16, 2301–2307, 1995.
   PubMed Web of Science ®Google Scholar
• Chenna, A. and Singer, B., Synthesis of a benzene metabolite adduct, 3’’-hydroxy-1,N2– benzetheno- 2’-deoxyguanosine, and its site-specific incorpo- ration in DNA oligonucleotides. Chem. Res. Toxicol. 10, 165–171, 1997.
   PubMed Web of Science ®Google Scholar
• Chenna, A. and Singer, B., Large scale synthesis of p-benzoquinone-2’deoxyxytidine and p- benzoquinone-2’-deoxyadenosine adducts and their site-specific incorporation into DNA oligonucleotides. Chem. Res. Toxicol. 8, 865– 874, 1995.
   Google Scholar
• Chenna, A., Hang, B., Rydberg, B., Kimm, E., Pongracz, K., Bodell, W.J., and Singer, B., The benzene metabolite p-benzoquinone forms adducts with DNA bases that are excised by a repair activity from human cells that differs from an ethenoadenine glycosylase. Proc. Natl. Acad. Sci. 92, 5890–5894, 1995.
   PubMed Web of Science ®Google Scholar
• Choy, N., MacGregor, J.T., Shelby, M.D., and Maronpot, R.R., Induction of micronuclei by benzene in B6C3F1 mice: Retrospective analysis of peripheral blood smears from the NTP carcinogenesis bioassay. Mut. Res. 143, 55–59, 1985.
   PubMedGoogle Scholar
• Ciranni, R., Barale, R., Ghelardini, G., and Lopieno, N., Benzene and the genotoxicity of its metabolites. II. The effect of the route of administration on the micronuclei and bone marrow depression in mouse bone marrow cells. Mut. Res. 209, 23–28, 1988.
   PubMed Web of Science ®Google Scholar
• Cohn, Z.A., The activation of mononuclear phago- cytes: Fact, fancy, and future. J. Immunol. 121, 813–816, 1978.
   PubMed Web of Science ®Google Scholar
• Cronkite, P.E., Bullis, J.E., Inoue, R., and Drew, R.T., Benzene inhalation produces leukemia in mice. Toxicol. Appl. Pharmacol. 75, 358– 361, 1984.
   PubMed Web of Science ®Google Scholar
• Cronkite, P.E., Drew, R.T., Inoue, T., Hirabayashi, Y., and Bullis, J.E., Hematotoxicity and car- cinogenicity of inhaled benzene. Environ. Health Perspect. 82, 97–108, 1989.
   PubMed Web of Science ®Google Scholar
• Cronkite, P.E., Inoue, R., Carten, A., Miller, M., Bullis, J., and Drew, R., Effects of benzene inhalation on murine pluripotent stem cells. J. Toxicol. Environ. Health 9, 411–421, 1982.
   PubMed Web of Science ®Google Scholar
• Crump, K.S., Risk of benzene-induced leukemia predicted from the Pliofilm cohort. Environ. Health Perspect. 104 (Suppl. 6), 1437–1441, 1996.
   Google Scholar
• Crump, K.S. and Allen, B.C. Quantitative esti- mates of risk of leukemia from occupational exposure to benzene. OSHA Docket H-059b, Exhibit 152 (Appendix B) Washington, DC, 1984. [As cited in Paustenbach et al., 1992]
   Google Scholar
• Daly, J.W., Jerina, D.M., and Witkop, B., Arene oxides and the NIH shift: the metabolism, toxicity and carcinogenicity of aromatic com- pounds. Experientia 28, 1129–1264, 1972.
   PubMedGoogle Scholar
• Deichmann, W., MacDonald, W., and Bernal, E., The hematopoietic tissue toxicity of ben- zene vapors. Toxicol. Appl. Pharmacol. 5, 201–244, 1963.
   PubMed Web of Science ®Google Scholar
• Delker, D.A., Yano, B.L., and Gollapudi, B.B., V-Ha-ras gene expression in liver and kidney of transgenic Tg.AC mice following chemi- cally induced tissue injury. Toxicol. Sci. 50, 90–97, 1999.
   PubMed Web of Science ®Google Scholar
• Delore, P. and Borgomano, C., Leucemie aigue au cours d’intoxication benzenique.’J. Méd. Lyon 9, 225 1928. [As cited in: Hamilton, A. Gen- eral Review: Benzene (benzol) poisoning. Arch. Pathol. 11, 434–454, 601–637, 1931].
   Google Scholar
• Dempster, A.M. and Snyder, C.A., Short term ben- zene exposure provides a growth advantage for granulopoietic cells over erythroid progeni- tor cells. Toxicology 64, 539–544, 1990.
   Google Scholar
• Dexter, T.M., Haemopoiesis in long-term bone marrow cultures. A review. Acta Haematol. 62, 299– 305, 1979.
   PubMed Web of Science ®Google Scholar
• Dexter, T.M., Wright, E.G., Krizsa, F., and Lajtha, L.G., Regulation of haematopoietic stem cell proliferation in long term Bone Marrow Cultures. Biomedicine 27, 344–349, 1977.
   PubMedGoogle Scholar
• Dosemeci, M., Li, G.-L., Hayes, R.B., Yin, S.-N., Linet, M., Chow, W.-H., Wang, Y.-Z., Jiang, Z.-L, Dai, T.-R., Zhang, W.-U., Chao, X.-J., Ye, P.-Z., Kou, Q-.R., Fan, Y.-H., Zhang, X.-C., Lin, X.-F., Meng, J.-F., Zho, J.-S., Wacholder, S., Kneller, R., and Blot, W.J. Cohort study among workers exposed to benzene in China: II. Exposure Assess- ment. Am. J. Ind. Med. 26,401–411,1994.
   PubMedGoogle Scholar
• Dovgy, A.I., Adrianov, N.V., Dzhuzenova, Ch.S., Alterman, M.A., and Archikov, A.I., Microheterogeneity of cytochrome P450(LM2) as revealed by isoelectric focusing. Biomed. Sci. 1, 475–480, 1990.
   PubMedGoogle Scholar
• Drummond, J.C. and Finar, I.L., Muconic acid as a metabolic product of benzene. Biochem. J. 32, 79–84, 1938.
   PubMedGoogle Scholar
• Eastmond, D.A., Smith, M.T., and Irons, R.D. An interaction of benzene metabolites repro- duces the myelotoxicity observed with ben- zene exposure. Toxicol. Appl. Pharmacol. 91, 85–95, 1987.
   PubMed Web of Science ®Google Scholar
• Emerson, S.G., The stem cell model of hemato- poiesis, in Hematology, Hoffman, R., Benz, E.J., Jr, Shattil, S.J., Furie, B., and Cohen, H.J., Eds., Churchill Livingstone, New York, 1991, Chapter 7, 72–81.
   Google Scholar
• Falconer, E.H., An instance of lymphatic leukemia following benzol poisoning. Am. J. Med. Sci. 186, 353–361, 1933.
   Google Scholar
• Farris, G.M., Everitt, J.I., Irons, R.D., and Popp, J.A., Carcinogenicity if inhaled benzene in CBA mice. Fund. Appl. Toxicol. 20, 503– 507, 1993.
   PubMedGoogle Scholar
• Farris, G.M., Robinson, S.N., Wong, B.A., Wong, V.A., Hahn, W.P., and Shah, R., Effects of benzene on splenic, thymic, and femoral lym- phocytes in mice. Toxicology 28, 137–148, 1997.
   Google Scholar
• Felix, C.A., Secondary leukemias induced by topoisomerase-targeted drugs. Biochem. Biophys. Acta 1400, 233–255, 1998.
   PubMed Web of Science ®Google Scholar
• Forni, A., Benzene-induced chromosome aberra- tions: a follow-up study. Environ. Health Perspect. 104(Suppl 6), 1309–1312, 1996.
   Google Scholar
• Forni, A. and Moreo, L., Cytogenetic studies in a case of benzene leukemia. Eup. J. Cancer 3, 251– 255, 1967.
   PubMedGoogle Scholar
• Forni, A. and Moreo, L., Chromosome studies in a case of benzene-induced erythroleukaemia. Eur. J. Cancer 5, 459–463, 1969.
   PubMed Web of Science ®Google Scholar
• Forni, A., Cappellini, A., Pacifico, E., and Vigliani, E.C., Chromosome changes and their evolution in subjects with past exposure to benzene. Arch. Environ. Health. 23, 385– 391, 1971.
   PubMed Web of Science ®Google Scholar
• Frantz, C.E., Chen, H., and Eastmond, D.A., Inhibition of human topoisomerase II in vitro by bioactive benzene metabolites. Environ. Health Perspect. 104 (Suppl. 6), 1319–1323,1996.
   Google Scholar
• Gaido, K.W. and Wierda, D., In vitro effects of benzene metabolites on mouse bone marrow stromal cells. Toxicol. Appl. Pharmacol. 76, 45–55, 1984.
   PubMed Web of Science ®Google Scholar
• Gaido, K.W. and Wierda, D., Modulation of stro- mal cell function in DBA 2/J and B6C3F1 mice exposed to benzene or phenol. Toxicol. Appl. Pharmacol. 81, 469–475, 1985.
   PubMed Web of Science ®Google Scholar
• Gaido, K.W. and Wierda, D., Suppression of bone marrow stromal cell function by benzene and hydroquinone is ameliorated by indometha- cin. Toxicol. Appl. Pharmacol. 89, 378–390, 1987.
   PubMed Web of Science ®Google Scholar
• Garda, H.A., Kruger, V.M., Sidhu, J., and Steir, A., Heterogeneity in rabbit liver cytochrome P450 LM2 observed by cation exchange HPLC: partial biochemical characterization of the two major LM2 subfractions. Mol. Cell Biochem. 14, 1–7 1994.
   Google Scholar
• Garnett, H.M., Cronkite, P.E., and Drew, R., Effect of in vivo exposure to benzene on the characteristics of bone marrow adherent cells. Leuk. Res. 7, 803–810, 1983.
   PubMed Web of Science ®Google Scholar
• Garton, G.A. and Williams, R.T., Studies in detoxication 17. The fate of catechol in the rabbit and the characterization of catechol monoglucuronide. Biochem. J. 43, 206–211, 1948.
   Web of Science ®Google Scholar
• Gill, D.P., Jenkins, V.K., Kempen, R.R., and Ellis, S., The importance of pluripotential stem cells in benzene toxicity. Toxicology 16, 163–171,1980.
   Google Scholar
• Gilmour, S.K.Kalf, G.F., and Snyder, R., Com- parison of the metabolism of benzene and its metabolite phenol in rat liver microsomes, In Biological Reactive Intermediates III Mecha- nisms of Action in ModelsAnimal and Hu- man Disease, Kocsis, JollowJ.J., , WitmerD.J., NelsonC.M., J.O., and Snyder, R., Eds., Plenum Publishing, New York, 1986, 223–235.
   Google Scholar
• Giver, C.R., Moore, D.H., II, and Pallavicini, M.G., Radiation-induced translocations in mice: persistence, chromosomes specificity, and influence of genetic background. Rad. Res. 154, 283–292, 2000.
   PubMedGoogle Scholar
• Goldstein, B.D., Myelogenous leukemia in rodents inhaling benzene. Toxicol. Lett. 13, 169–173, 1982.
   PubMed Web of Science ®Google Scholar
• Goldstein, B.D., Witz, G., Javid, J., Amoruso, M., Rossman, T., and Wolder, B.,Muconaldehyde, a potential toxic intermediate of benzene me- tabolism, In Biological Reactive Intermediates. Snyder, R., Parke, D.V., Kocsis, J.J., Jollow, D.J.,Gibson G.G., and Witmer, C.M., Eds., Ple- num, New York, 1982, Vol. 2, 331–339.
   Google Scholar
• Gollmer, L., Graf, H., and Ullrich, V., Character- ization of the benzene monooxygenase sys- tem in rabbit bone marrow. Biochem. Pharmacol. 15, 3597–3602, 1984.
   Google Scholar
• Gonasun, L.M., Witmer, C., Kocsis, J.J., and Snyder, R., Benzene metabolism in mouse liver microsomes. Tox. Appl. Pharmacol. 26, 398–406, 1973.
   PubMed Web of Science ®Google Scholar
• Goon, D., Cheng, X., Ruth, J.A., Peterson, D.R. and Ross, D. metabolism of trans,trans- muconaldehyde by aldehyde and alcohol de- hydrogenases: Identification of a novel me- tabolite. Toxicol. Appl. Pharmacol. 114, 147–155, 1992.
   PubMed Web of Science ®Google Scholar
• Green, J., Snyder, C.A., Goldstein, B.D., and Albert, R., Acute and chronic dose/response effect of benzene inhalation on the peripheral blood, bone marrow, and spleen cells of CD- 1 male mice. Toxicol. Appl. Pharmacol. 59, 204–214, 1981.
   PubMed Web of Science ®Google Scholar
• Greenberg, P.L., Myelodysplastic syndrome, in Hematology, 2nd ed., Hoffman, R., Benz, E.J., Jr, Shattil, S.J., Furie, B., Cohen, H.J., and Silberstein, L.E., Eds., Churchill Livingstone, New York, 1995, Chapter 71, 1098–1121.
   Google Scholar
• Greenberg, P.L., Myelodysplastic syndrome, in Hematology, 3nd ed., Hoffman, R., Benz, E.J., Jr, Shattil, S.J., Furie, B., Cohen, H.J., Silberstein, L.E., and McGlace, P. Eds., Churchill Livingstone, New York, 2000, Chapter 60, 1111.
   Google Scholar
• Greenburg, L., Mayers, M.R., Goldwater, L., and Smith A.R., Benzene (benzol) poison- ing in the rotogravure printing industry in New York City. J. Ind. Hyg. Toxicol. 21, 395–420, 1939.
   Google Scholar
• Gross, S., Helm, K., Gruntmeir, J.J., Stillman, W.S., Pyatt, D.W., and Irons, R.D., Characterization and phenotypic analysis of differentiating CD34+ human bone marrow cells in liquid cul- ture. Eur. J. Haematol. 58, 318–326, 1997.
   Google Scholar
• Grue, P., Gräfert, A., Sehested, M., Jensen, P.B., Uhse, A., Straub, T., Ness, W., and Boege, F., Essential mitotic function of DNA topoisomerase II are not adopted by topoisomerase Ii in human H69 cells. J. Biol. Chem. 273, 33660–33666, 1998.
   PubMedGoogle Scholar
• Guy R., Dimitriadis, E., Hu, P., Cooper, K., and Snyder, R., Interactive Inhibition of Eryth- roid 59Fe Utilization by Benzene Metabolites in Female Mice. Chem.-Biol. Interactions 74, 55– 62, 1990.
   PubMed Web of Science ®Google Scholar
• Guy, R.L., Hu, P., Witz, G., Goldstein, B.D., and Snyder, R., Depression of Iron Uptake Into Erythrocytes in Mice by Treatment with the Combined Benzene Metabolites P-benzo- quinone, Muconaldehyde and Hydroquinone. J. Appl. Toxicol. 11, 443–446, 1991.
   PubMed Web of Science ®Google Scholar
• Hamilton-Patterson, J.L. and Browning, E., Toxic effects in women exposed to industrial rubber solutions. Brit. Med. J. I, 349–352, 1944.
   Google Scholar
• Hansen, L.A., Trempus, C.S., Mahler, J.F., and Tennant, R.W., Association of tumor devel- opment with increased cellular proliferation and transgenic overexpression, but not c- Ha- ras mutations, in v-Ha-ras transgenic Tg.AC mice. Carcinogenesis 17, 1825, 1996.
   Google Scholar
• Hanzlik, R.P., Hogberg, K., and Judson, C.M., Microsomal hydroxylation of specifically deuterated monosubstituted benzene. Evi- dence for direct aromatic hydroxylation. Bio- chemistry 23, 3048–3055, 1984.
   Google Scholar
• Harigaya, K., Miller, M., Cronkite, E., and Drew, R., The detection of in vivo hematotoxicity of benzene by in vitro liquid bone marrow cul- tures. Toxicol. Appl. Pharmacol. 60, 346–353, 1981.
   PubMed Web of Science ®Google Scholar
• Harnden, D.G., Klinger, H.P., Jensen, J.T., and Kaebling, M., Eds. An International System for Human Cytogenetic Nomenclature. Re- port of the Standing Committee on Human Cytogenetic Nomenclature. S. Karger, Basel 1985.
   Google Scholar
• Haugen, D.A. and Coon, M.J., Properties of elec- trophoretically homogeneous phenobarbital- inducible and beta-naphthoflavone-inducible forms of liver microsomal cytochrome P-450. J. Biol. Chem. 251, 7929–7939, 1976.
   PubMed Web of Science ®Google Scholar
• Hayes, R.B., Yin, S-N., Dosemeci, M., Li, G-L., Wacholder, S., Travis, L.B., Li, C-Y., Rothman, N., Hoover, R.N., and Linet, M.S. Benzene and the dose-related incidence of hematologic neoplasms in China. J. Natl. Cancer Inst., 89, 1065–1070,1997.
   PubMedGoogle Scholar
• Hazel, B.A. and Kalf, G.F., Induction of granulo- cytic differentiation in myeloblasts by hydro- quinone, a metabolite of benzene, involves the leukotriene D4 receptor. Recept. Signal Transduct. 6, 1–12, 1996a.
   PubMedGoogle Scholar
• Hazel, B.A., Baum, C., and Kalf, G.F., Hydro- quinone, a bioreactive metabolite of benzene, inhibits apoptosis in myeloblasts. Stem Cells 14, 730–742, 1996b.
   PubMed Web of Science ®Google Scholar
• Hazel, B.A., O’Connor, A., Niculescu, R., and Kalf, G.F., Induction of granulocytic differ- entiation in a mouse model by benzene and hydroquinone. Environ. Health Perspect. 104 (Suppl. 6), 1257–1264, 1996c.
   Google Scholar
• Hazel, B.A., O’Connor, A., Niculescu, R., and Kalf, G.F., Benzene and its metabolite, hyd- roquinone, induce granulocytic differentiation in myeloblasts by interacting with cellular signaling pathways activated by granulocyte colony-stimulating factor. Stem Cells 13, 295–310, 1995.
   Google Scholar
• Hedli, C.C. Evaluation of the Potential Role of DNA Adducts in Benzene Toxicity. Ph.D. Thesis, Rutgers University, New Brunswick, NJ, 1994.
   Google Scholar
• Hedli, C.C., Hoffmann, M.J., Ji, S., Thomas, P.E., and Snyder, R., Benzene metabolism in the isolated perfused mouse liver. Toxicology and Applied Pharmacology 146, 60–68 1997.
   PubMed Web of Science ®Google Scholar
• Hedli, C.C., Rao, N.R., Reuhl, K.R., Witmer, C.M., and Snyder, R., Effects of benzene metabolite treatment on granulocytic differ- entiation and DNA adduct formation in HL- 60 cells. Archives of Toxicology 70, 135–145, 1996.
   PubMed Web of Science ®Google Scholar
• Hedli, C.C., Snyder, R., and Witmer, C.M., Bone marrow DNA adducts and bone marrow cel- lularity following treatment with benzene metabolites in vivo, In Biological Reactive Intermediates IV. Molecular and Cellular Effects and Their Impact on Human Health. Witmer, C.M., Snyder, R., Jollow, D.J., Kalf,
   Google Scholar
• G.F., Kocsis, J.J., and Sipes, I.G., Eds., 1991, 745–758.
   Google Scholar
• Hektoen, L., Effect of benzene on the production of antibodies. J. Infec. Dis. 19, 69–84, 1916.
   Google Scholar
• Helmer, K.J., Accumulated cases of benzene poi- soning in the rubber industry. Acta Med. Scand. 118, 354–375, 1944.
   Google Scholar
• Hildebrand, R.L. and Murphy, M.J., Jr., The effects of benzene inhalation on murine he- matopoietic precursor cells (CFU-e, BFU-e and CFU-gm). Int. J. Cell Cloning 1, 240– 253, 1983.
   PubMedGoogle Scholar
• Hirschfelder, A.D. and Winternitz, M.C., Stud- ies upon experimental pneumonia in rabbits. J. Exp. Med. 17, 657–665, 1913.
   PubMedGoogle Scholar
• Hite, M., Pecharo, M., Smith, I., and Thornton, S., The effect of benzene in the micronucleus test. Mut. Res. 77, 149–155, 1980.
   PubMedGoogle Scholar
• Hodges, V.M., Molloy, G.Y., and Wichramasinghe, S.N., Demonstration of mRNA for five species of cytochrome P450 in human bone marrow, bone marrow-derived macrophages and hu- man haemopoietic cell lines. Brit. J. Haemat. 108, 151–156, 2000.
   PubMed Web of Science ®Google Scholar
• Hoffmann, M.J., Ji, S., and Snyder, R., Metabo- lism of [14C]Phenol in the Isolated Perfused Mouse Liver. Toxicological Sciences 49, 40–47, 1999.
   PubMed Web of Science ®Google Scholar
• Hoffman, M.J., Sinko, P.J., Lee, Y.-H., Meeker, R.J. and Snyder, R. Pharmacokinetic stud- ies inTg.Ac and FVB mice administered [14C]benzene either by oral gavage or intrad- ermal injection. Toxicol. Appl. Pharmacol. 174, 139–145, 2001.
   Google Scholar
• Hoffmann, M.J., Sinko, P.J., Meeker, R.J., and Snyder, R., Pharmacokinetics of benzene following oral or intradermal dose in FVB and Tg.AC mice. Sixth International Sympo- sium on Biological Reactive Intermediates: chemical and biological mechanisms in sus- ceptibility to and prevention of environmen- tal diseases, Université René Descartes, Paris, 2000.
   Google Scholar
• Hough, V. and Freeman, S., Relative toxicity of commercial benzene and a mixture of ben- zene, toluene, and xylene. Fed. Proc. 3, 20, 1944.
   Google Scholar
• Huff, J.E., Haeman, J.K., DeMarini, D.M., Eustis, S., Maronpot, R.R., Peters, A.C., Peprsing, R.L., Chrisp, C.E., and Jacobs, A.C., Mul- tiple-site carcinogenicity of benzene in Fischer 344 rats and B6C3F1 mice. Environ. Health Perspect. 82,125–163, 1989.
   PubMed Web of Science ®Google Scholar
• Hunter, D., The Diseases of Occupations. Little Brown and Company, Boston, 1962.
   Google Scholar
• Hutt, A.M. and Kalf, G.F., Inhibition of human DNA topoisomerase II by hydroquinone and p- benzoquinone, reactive metabolites of ben- zene. Environ. Health Perspect. 104(Suppl.6), 1265–1269, 1996.
   Google Scholar
• Infante, P.F., Rinsky, R.A., Wagoner, J.K., and Young, R.J., Leukemia in benzene workers. Lancet. 2, 76–78, 1977.
   PubMed Web of Science ®Google Scholar
• Inoue, O, Seiji, K., and Ikeda, M., Pathways for formation of catechol and 1,2,4–benzenetriol in rabbits. Bull. Environ. Contam. Toxicol. 43, 220–224, 1989a.
   PubMedGoogle Scholar
• Inoue, O., Seiji, K., Nakatsuka, H., Watanabe, T., Yin, S-N., Li, G-L., Cai, S-X., Jin, C., and
   Google Scholar
• Ikeda, M., Excretion of 1,2,4–benzenetriol in the urine of workers exposed to benzene. Brit. J. Ind. Med. 46, 559–565, 1989b.
   PubMedGoogle Scholar
• Irons, R., Dent, J., Baker, T., and Rickert, D., Benzene is metabolized and covalently bound in bone marrow in situ. Chem. Biol. Interact. 30, 241–245, 1980.
   PubMed Web of Science ®Google Scholar
• Irons, R.D., Studies on the mechanism of chemi- cally induced leukemia/lymphoma. CIIT Ac- tivities 8, 1–8, 1988.
   Google Scholar
• Irons, R.D. and Moore, B.J., Effect of short term benzene administration on circulating lym- phocyte subpopulations in the rabbit: evidence of a selective B-lymphocyte sensitivity. Res. Commun. Chem. Pathol. Pharmacol. 27, 147–155, 1980.
   PubMedGoogle Scholar
• Irons, R.D. and Stillman, W.S., Cell proliferation and differentiation in chemical leukemogen- esis. Stem Cells 11, 235–242, 1993.
   PubMed Web of Science ®Google Scholar
• Irons, R.D. and Stillman, W.S., Impact of ben- zene metabolites on differentiation of bone marrow progenitor cells. Environ. Health Perspect. 104(Suppl. 6), 1996a.
   Google Scholar
• Irons, R.D. and Stillman, W.S., The effects of benzene and other leukemogenic agents on haematopoietic stem and progenitor cell dif- ferentiation. Eur. J. Haematol. 57(Suppl.), 119– 124, 1996b.
   Google Scholar
• Irons, R.D., Neptun, D.A., and Pfiefer, R.W., Inhibition of lymphocyte transformation and microtubule assembly by quinone metabo- lites of benzene. J. Reticuloendothel. Soc. 30, 359– 372, 1981.
   PubMedGoogle Scholar
• Irons, R.D., Stillman, W.S., Colagiovanni, D.B., and Henry, V.A., Synergistic action of the benzene metabolite hydroquinone on my- elopoietic stimulating activity of granulocyte/ macrophage colony stimulating factor in vitro. Proc. Natl. Acad. Sci. USA 89, 3691–3695, 1992.
   PubMed Web of Science ®Google Scholar
• Jerina, D. and Daly, J.W., Arene oxides: A new aspect of drug metabolism. Science 185, 573– 582, 1974.
   PubMed Web of Science ®Google Scholar
• Jerina, D., Day, J., Witkop, B., Zaltzman- Nirenberg, P., and Udenfriend, S., Role of arene oxide-oxepin system in the metabolism of aromatic substrates. 1. In vitro conversion of benzene oxide to a premercapturic acid and a dihydrodiol. Arch. Biochem. Biophys. 128, 176–183, 1968.
   Web of Science ®Google Scholar
• Johansson, I. and Ingelman-Sundberg, M., Hy- droxyl radical-mediated, cytochrome P-450– dependent metabolic activation of benzene in microsomes and reconstituted enzyme sys- tems from rabbit liver. J. Biol. Chem. 258, 7311–7316, 1983.
   PubMed Web of Science ®Google Scholar
• Jowa, L., Witz, G., Snyder, R., Winkle, S., and Kalf, G.F., Synthesis and characterization of deoxyguanosine-benzoquinone adducts. J. Appl. Toxicol. 10, 47–54, 1990.
   PubMed Web of Science ®Google Scholar
• Kalf, G.F. and O’Connor, A., The effects of benzene and hydroquinone on myeloid dif- ferentiation of HL-60 promyelocytic leuke- mia cells. Leuk. Lymphoma 11, 331–338, 1993.
   PubMed Web of Science ®Google Scholar
• Kalf, G.F., Renz, J.F., and Niculescu, R., p-Ben- zoquinone, a reactive metabolite of benzene, prevents the processing of pre-interleukins-1 alpha and -1 beta to active cytokines by inhi- bition of the processing enzymes, calpain, and interleukin-1 beta converting enzyme. Environ. Health Perspect. 104(Suppl 6), 1251–1256, 1996.
   Google Scholar
• Karacic, V., Skender, L., Bosner-Cucancic, B., and Bogadi-Sare, A., Possible genotoxicity in low level benzene exposure. Am. J. Ind. Med. 27, 379–388, 1995.
   PubMed Web of Science ®Google Scholar
• Karnovsky,M.L. and Lazdins, J.K. Biochemical criteria for activated macrophages. J. Immunol. 121, 809–813, 1978.
   PubMedGoogle Scholar
• Kawanishi, S., Inoue, S., and Kawanishi, M., Human DNA damage induced by 1,24,- benzenetriol, a benzene metabolite. Cancer Res. 49, 164–168, 1989.
   PubMed Web of Science ®Google Scholar
• Kim, D.D., Hoffmann, M.J., Akbar, M., Kalf, G.F., and Snyder, R., The potential role of topoisomerase II inhibition in hydroquinone- induced alterations in the maturation of 32D3.3 (g) cells. Proceedings of the Sixth International Symposium on Biological In- termediates: chemical and biological mecha- nisms in susceptibility to and prevention of environmental diseases. Université René Descartes, Paris 2000, 26.
   Google Scholar
• Kingma, P.S. and Osheroff, N., The response of eukaryotic topoisomerases to DNA damage. Biochem. Biophys Acta 1400, 223–232, 1998.
   PubMedGoogle Scholar
• Kline, S.A., Robertson, J.F., Grotz, V.L., Goldstein, B.D., and Witz, G. Identification of 6–hydroxy-trans,trans-2,4–hexadienoic acid, a novel ring-opened urinary metabolite of benzene. Environ. Health Perspect. 101, 310–312, 1993.
   PubMedGoogle Scholar
• Knox, W.E., Pyrocatechase in Biochemists Hand- book. Long, C., Kong, E.J., and Sperry, W.M., Eds., D. Van Nostrand Company, Inc. Princeton,1961, 377.
   Google Scholar
• Koop, D.R., Laethem, C.L., and Schnier, G.G., Identification of ethanol-inducible P450 isozyme 3a (P450IIE1) as a benzene and phe- nol hydroxylase. Toxicol. Appl. Pharmacol. 98, 278–288, 1989.
   PubMed Web of Science ®Google Scholar
• Kuo, M.L., Chou, Y.W., Chau, Y.P., and Huang, T.S., Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function. Mol. Carcino. 18, 221–231, 1997.
   PubMedGoogle Scholar
• Larsen, A.K., Gobert, C., Gilbert, C., Markovits, J., and Bojanowski, K., DNA topoisomerases as repair enzymes: mechanism(s) of action and regulation by p53. Acta Biochem. Pol. 45, 535–544, 1998.
   PubMedGoogle Scholar
• Laskin, D.L. and Pilaro, A.W. Potential role of activated macrophages in acetaminophen- hepatotoxicity. I. Isolation and characteriza- tion of activated macrophages from rat liver. Toxicol. Appl. Pharmacol. 86, 204–215, 1986.
   PubMed Web of Science ®Google Scholar
• Laskin, D.L., MacEachern, L., and Snyder, R., Activation of bone marrow phagocytes fol- lowing benzene treatment of mice. Environ. Health Perspect. 82, 75–79, 1989.
   PubMed Web of Science ®Google Scholar
• Laskin, J.D., Rao, N.R., Punjabi, C.J., Laskin, D.L., and Snyder, R., Distinct actions of benzene and its metabolites on nitric oxide production by bone marrow leukocytes. J. Leuk. Biol. 57, 422–426, 1995.
   PubMed Web of Science ®Google Scholar
• Laskin, D.L. and Pendino, K.J. Macrophages and inflammatory meddiators in tissue injury. An. Rev. Pharmacol. Toxicol. 53, 655–677, 1995.
   Google Scholar
• Laskin, J.D. and Laskin, D.L. (eds.) Cellular and molecular biology of nitric oxide. Marcel Dekker, New York, 1999.
   Google Scholar
• Laskin, D.L., Heck, D.E., Punjabi, C.J. and Laskin, J.D. Nitric oxide as a mediator of benzene- induced hematosuppressions and toxicity. J. Toxicol. Environ. Health 61 (Part A), 413–417, 2000.
   Google Scholar
• Latriano, L., Goldstein, B.D., and Witz, G., For- mation of muconaldehyde, an open ring me- tabolite of benzene, in mouse liver mi- crosomes. Proc. Natl. Acad. Sci. USA 83, 8356–8360, 1986.
   PubMed Web of Science ®Google Scholar
• Lau, S.S., Hill, B.A., Highet, R.J., and Monks, T.J., Sequential oxidation and glutathione addition to 1,2–benzoquinone: correlation of toxicity with increased glutathione substitu- tion. Mol. Pharmacol. 34, 829–836, 1988.
   PubMed Web of Science ®Google Scholar
• Le Beau, M.M. and Larson, R.A., Cyogenetics and neoplasia. In: Hematology: Basic Prin- ciples and Practice. Hoffman, R., Benz, E.J., Jr, Shattil, S.J., Furie, B., and Cohen, H.J., Eds. Churchill Livingstone, New York 1991, 638–655.
   Google Scholar
• Le Beau, M.M. and Larson, R.A. Cytogenetics and neoplasia, in Hematology, 3nd ed., Hoffman, R., Benz, E.J., Jr, Shattil, S.J., Furie, B., Cohen, H.J., Silberstein, L.E., and McGlace, P. Eds., Churchill Livingstone, New York, 2000, Chapter 48, 848–869.
   Google Scholar
• Lee, E.W., Kocsis, J.J. and Snyder, R., Benzene: Acute effect on 59Fe incorporation into circu- lating erythrocytes. Toxicol. Appl. Pharmacol. 27, 431–436, 1974.
   PubMed Web of Science ®Google Scholar
• Le Noir, M.M. and Claude, H., [A case of purpura attributed to benzene poisoning.] Bull. Méd. Hôp. Paris, 14: 151–60, (1897). [As cited in Golding, B.T. and Watson, W.P. Possible mechanisms of carcinogenesis after exposure to benzene. In: Exocyclic DNA Adducts in Mutagenesis and Carcinogenesis, Singer B. and Bartsch H., Eds., IARC Scientific Publi- cations, IARC, Lyon, 1999.]
   Google Scholar
• Leone, G., Mele, L., Pulsoni, A., Equitani, F., and Pagano, J., The incidence of secondary leukemias. Haematologica 84, 937–945, 1999.
   PubMed Web of Science ®Google Scholar
• Lerum, A.D., Reticulum cell neoplasms in normal and benzene treated hairless mice. Acat Path. Microbiol. 81, 57–63, 1973.
   Google Scholar
• Levay, G. and Bodell, W.J., Potentiation of DNA adduct formation in HL-60 cells by combina- tions of benzene metabolites. Proc. Natl. Acad. USA 89, 7105–7109, 1992.
   PubMed Web of Science ®Google Scholar
• Levay, G., Pongracz, K., and Bodell, W.J., De- tection of DNA adducts in HL-60 cells treated with hydroquinone and p-benzoquinone by 32P-postlabeling. Carcinogenesis 12, 1181–1186, 1991.
   PubMed Web of Science ®Google Scholar
• Levay, G., Ross, D., and Bodell, W.J., Peroxidase activation of hydroquinone results in the for- mation of DNA adducts in HL-60 cells, mouse bone marrow macrophages and human bone marrow. Carcinogenesis 14, 2329–2334, 1993.
   PubMedGoogle Scholar
• Li, G., Wang, C., Xin, W., and Yin, S., Tissue distribution of DNA adducts and their persis- tence in blood of mice exposed to benzene. Environ. Health Perspect. 104(Suppl.6), 1337–1337, 1996.
   Google Scholar
• Li, S.-H., Bandy, B., Tsang, S.-S., and Davison,A.J. DNA breakage induced by 1,2,4–benzenetriol: relative contributions of xygen-derived active species and transition metal ions. Free Radic. Biol. Med. 30, 943–956, 2001.
   PubMedGoogle Scholar
• Li, T-K. And Liu, L.F., Tumor cell death induced by topoisomerase-targeting drugs. Annu. Rev. Pharmacol. Toxicol. 41, 53–77, 2001.
   PubMed Web of Science ®Google Scholar
• Lignac, G.O.E., Benzene induced leukemia in hu- mans and white mice. Klin. Wochenschr. 12:109– 110 (1933). [The paper was origi- nally written in German. It was helpful to have available in an English translation pre- pared by Leo Kanner Associates, Redwood City, CA in 1977.]
   Google Scholar
• Lindstrom, A.B., Yeowell-O’Connel, K., Waidyanatha, S., Golding, B.T., Tornero- Velez, R., and Rappaport, S.M., Measure- ment of benzene oxide in the blood of rats following administration of benzene. Car- cinogenesis 18, 1637–1641, 1997.
   PubMed Web of Science ®Google Scholar
• Lindstrom, A.B., Yeowell-O’Connell, K., Waidyanatha, S., McDonald, T.A., Golding, B.T., and, S.M., Formation of hemoglobin and albumin adducts of benzene oxide in mouse, rat and human blood. Chem. Res. Toxicol. 11, 302–310, 1998.
   PubMed Web of Science ®Google Scholar
• Lipton, J.M., Histiocytic syndromes, in Hematol- ogy, 2nd edition, Hoffman, R., Benz, E.J., Shattil, S.J., Furie, B., Cohen, H.J., and Silberstein, L.E., Eds., Churchill Livingstone, New York, 1995, 840–841.
   Google Scholar
• London, S.J., Lehman, T.A., and Taylor, J.A., Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res. 57, 5001–5003, 1997.
   PubMed Web of Science ®Google Scholar
• Longacre, S.L., Kocsis, J.J., and Snyder, R., In- fluence of strain differences in mice on the metabolism and toxicity of benzene. Toxicol. Appl. Pharmacol. 60, 398–409, 1981b.
   PubMed Web of Science ®Google Scholar
• Longacre, S.L., Kocsis, J.J., Witmer, C.M., Lee, E.W., Sammett, D., and Snyder, R., Toxi- cological and biochemical effects of repeated administration of benzene to mice. J. Toxicol. Environ. Health 7, 223–237 1981a.
   PubMed Web of Science ®Google Scholar
• Lovern, M.R., Turner, M.J., Meyer, M., Kedderis, G.L., Bechtold, W.E., and Schlosser, P.M., Identification of benzene oxide as a product of benzene metabolism by mouse, rat and human liver microsomes. Carcinogenesis 18, 1695–1700, 1997.
   PubMed Web of Science ®Google Scholar
• Lutz,W.K., In vivo covalent binding of organic chemicals to DNA as a quantitative indicator in the process of chemical carcinogenesis. Mut. Res. 65, 289–356, 1979.
   PubMed Web of Science ®Google Scholar
• Lutz, W.K. and Schlatter, C., Mechanism of the carcinogenic action of benzene: irreversible binding to rat liver DNA. Chem.-Biol. Inter- actions 18, 241–245, 1977.
   PubMed Web of Science ®Google Scholar
• MacEachern, L. and Laskin, D.L., Increased pro- duction of tumor necrosis factor-alpha by bone marrow leukocytes following benzene treat- ment of mice. Toxicol. Appl. Pharmacol. 113, 260–266, 1992.
   PubMed Web of Science ®Google Scholar
• MacEachern, L., Snyder, R. and Laskin, D.L. Alterations in the morphology and functional activity of bone marrow phagocytes follow- ing benzene treatment in mice. Toxicol. Appl. Pharmacol. 117, 147–154, 1992.
   PubMed Web of Science ®Google Scholar
• Mallory, T.B., Gall, E.A., and Brickley, W.J., Chronic exposure to benzene (benzol). III. The pathologic results. J. Ind. Hyg. Toxicol. 21, 355–393, 1939.
   Google Scholar
• Maltoni, C. and Scarnato, C., First experimental demonstration of the carcinogenic effects of benzene. Med. Lav. 5, 352–357, 1979.
   Google Scholar
• Maltoni, C., Conti, B., and Cotti, G., Benzene: multipotential carcinogen. Results of long term bioassay performed at the Bologna Institute of Oncology. Am. J. Ind. Med. 4, 589–630, 1983.
   PubMed Web of Science ®Google Scholar
• Maltoni, C., Cotti, G., Valgimigli, L., and Mandrioli, A., Zymbal gland carcinomas in rats following exposure to benzene by inhala- tion. Am. J. Ind. Med. 3, 11–16, 1982.
   PubMedGoogle Scholar
• Matthews, J.M., Etheridge, A.S., and Matthews, H.B., Dose-dependent metabolism of benzene in hamsters, rats, and mice. Toxicol. Sci. 44, 14–21, 1998.
   PubMedGoogle Scholar
• McDonald, T.A., Waidyanatha, S., and Rappaport, S.M., Production of benzoquinone adducts with hemoglobin and bone marrow protein follow- ing administration of [13C6]benzene to rats. Carcinogenesis 14,1921–1925, 1993.
   PubMed Web of Science ®Google Scholar
• McDonald, T.A., Yeowell-O’Connell, K., and Rappaport, S.M., Comparison of protein adducts of benzene oxide and benzoquinone in the blood and bone marrow of rats and mice exposed to [14C/13C6]benzene. Cancer Res. 54, 4907–4914, 1994.
   PubMed Web of Science ®Google Scholar
• Mehrotra, B., George, T.I., Kavanau, K., Avert- Loiseau, H., Moore, D. II, Willman, C.L., lovak, M.L., Atwater, S., Head, D.R. and Pallavicini, M.G., Cytogenetically aberrant cell in the stem cell compartment (CD34+lin-) in acute myeloid leukemia. Blood 86, 1139– 1147, 1995.
   PubMedGoogle Scholar
• Merlat, A., Lai, J.L., Sterkers, Y., Demory, J.L., Bauters, F., Preudhomme, C., and Fenaux, P., Therapy-related myelodysplastic syndrome and acute myeloid leukemia with 17p dele- tion. Leukemia 13, 250–257, 1999.
   PubMed Web of Science ®Google Scholar
• Meyer, K.N., Kjeldsen, R., Straub,T, Knudesen, B.R., Hickson, I.D., Kikuchi, A., Kreipe, H., and Boege, F., Cell cycle-coupled reloca- tion of types I and II topoisomerases and modulation of catalytic enzyme activities. J. Cell Biol. 136, 775–788, 1997.
   PubMedGoogle Scholar
• Miller, E.C. and Miller J.A., Reactive metabolites as key intermediates in pharmacologic and toxicologic responses: examples from chemi- cal carcinogenesis. In: Biological Reactive Intermediates -II: Chemical Mechanisms and Biological Effects, Snyder, R., Parke, D.V., Kocsis, J.J., Jollow, D.J., Gibson, G.G., and Witmer, C.M., Eds., Plenum Press, New York, 1982, 1–21.
   Google Scholar
• Miller, K.B., Clinical manifestations of acute my- eloid leukemia, in Hematology, 2nd ed., Hoffman, R., Benz, Jr., E.J., Shattil, S.J., Furie,
   Google Scholar
• B., Cohen, H.J., and Silberstein, L.E., Eds., Churchill Livingstone, New York, 1995, 993–1014.
   Google Scholar
• Moran, J.L., Siegel, D., Sun, X.M., and Ross D., Induction of apoptosis by benzene metabo- lites in HL-60 and CD34+ human bone mar- row progenitor cells. Mol. Pharmacol. 50, 610–615, 1996.
   PubMed Web of Science ®Google Scholar
• Moran, J.L., Siegel, D., and Ross D., A potential mechanism underlying the increased suscep- tibility of individuals with a polymorphism in NAD(P)H: quinoneoxidoreductase 1 (NQ01) to benzene toxicity. Proc. Natl. Acad. Sci. USA 96, 8150–8155, 1999
   PubMed Web of Science ®Google Scholar
• Morimoto, K., Induction of sister chromatid ex- change and cell division delays in human lym- phocytes by microsomal activation of ben- zene. Cancer Res. 43, 1330–1334, 1983a.
   PubMed Web of Science ®Google Scholar
• Morimoto, K., Wolff, S., and Koizumi, A., Induc- tion of sister chromatid exchanges in human lymphocytes by microsomal activation of benzene. Mut. Res. 119, 355–360, 1983b.
   PubMed Web of Science ®Google Scholar
• Nerland, D.E. and Pierce, W.M., Jr., Identifica- tion of N-acetyl-S-(2,5–dihydroxyphenyl)-L- cysteine as a urinary metabolite of benzene, phenol and hydroquinone. Drug Metab. Dispos. 18, 958–961, 1990.
   PubMed Web of Science ®Google Scholar
• Niculescu, R. and Kalf, G.F., A morphological analysis of the short-term effects of benzene on the development of the hematological cells in the bone marrow of mice and the effects of interleukin-1 on the process. Arch. Toxicol. 69, 141–148, 1995.
   PubMed Web of Science ®Google Scholar
• North, R.J. The concept of the activated macroph- age. J. Immunol. 121, 806–809, 1978.
   PubMed Web of Science ®Google Scholar
• Oliveira, N.L. and Kalf, G.F., Induced differentia- tion of HL-60 promyelocytic leukemia cells to monocyte/macrophages is inhibited by hydroquinone, a hematotoxic metabolite of benzene. Blood 79, 627–633, 1992.
   PubMed Web of Science ®Google Scholar
• Orzechowski, A., Schwarz, L.R., Schwegler, U., Bock, K.W., Snyder, R., and Schrenk, D., Benzene metabolism in rodent hepatocytes: Role of sulfate conjugation. Xenobiotica 25, 1093–1102, 1995.
   PubMed Web of Science ®Google Scholar
• Ott, M.G., Townsend, J.C., Fishbeck, W.A., and Langner, R.A., Mortality among individuals occupationally exposed to benzene. Arch. Environ. Health 33, 3–10, 1978.
   PubMed Web of Science ®Google Scholar
• Pandya, K.P., Rao, G.S., Khan, S., and Krishnamurthy, R., Accumulation of low molecular weight (bleomycin detectable) iron in bone marrow cells of rats after benzene exposure. Arch. Toxicol. 64, 339–342, 1990.
   PubMedGoogle Scholar
• Parke, D.V., Personal reflections on 50 years of study of benzene toxicology. Environ. Health Perspect. 104(Suppl. 6), 1123–1128, 1996.
   Google Scholar
• Parke, D.V. and Williams, R.T., Studies in detoxi- cation 49. The metabolism of benzene con- taining [14C1] benzene. Biochem. J. 54, 231– 238, 1953a.
   PubMed Web of Science ®Google Scholar
• Parke, D.V. and Williams, R.T., Studies in detoxica- tion 54. The metabolism of benzene. (a) the for- mation of phenylglucuronide and phenylsulfuric acid from [14C] benzene. (b) the metabolism of phenol. Biochem J. 55, 337–340, 1953b.
   PubMed Web of Science ®Google Scholar
• Paustenbach, D.J., Price, P.S., Ollison, W., Blank, C., Jernigan, J.D., Bass, R.D., and Peterson, H.D., Reevaluation of benzene exposure for the Pliofilm (rubber worker) cohort. Toxicol. Environ. Health 36, 177–231, 1992. ederson-Bjergaard, J. and Rowley, W., The balanced and unbalanced chromosome aber- rations of acute myeloid leukemia may de- velop in different ways and may contribute differently to malignant transformations. Blood 83, 2780–2786, 1994.
   PubMed Web of Science ®Google Scholar
• Pederson-Bjergaard, J., Pederson, M., Roulston, D., and Preben, P., Different pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy related acute myeloid leukemia. Blood 86: 3542–3552, 1995.
   PubMedGoogle Scholar
• Penati, F. and Vigliani, E.C., Sul problema delle mielopatie aplastische pseudoaplastische e leucemiche d benzolo. Ras. Med. Ind. 9, 345– 361, 1938.
   Google Scholar
• Penning, T.M. and Sharp, R.B., Characterization of dihydrodiol dehydrogenase in human liver and lung. Carcinogenesis 11, 1203–1208, 1990.
   PubMedGoogle Scholar
• Pfeifer, D. and Irons R.D., Inhibition of lectin- stimulated lymphocyte agglutination and mi- togenesis by hydroquinone: reactivity with intracellular sulfhydryl groups. Exp. Mol. Pathol. 35, 189–198, 1981.
   PubMed Web of Science ®Google Scholar
• Pfeifer, D. and Irons R.D., Effect of benzene metabolites on phytohemagglutinin-stimulated lymphopoiesis in rat bone marrow. J. Reticuloendothel. Soc. 31, 155–170, 1982.
   PubMedGoogle Scholar
• Pollini, G. and Colombi, R., Il danno cromosomammidollare nell anaemia aplastica benzolica. Med. Lav. 55, 244–255, 1964.
   Google Scholar
• Pongracz, K. and Bodell, W.J., Detection of 3’- hydroxy-1,N6–benzetheno-2’-deoxyadenosine- 3’- phosphate by 32P postlabeling of DNA reacted with p-benzoquinone. Chem. Res. Toxicol. 4, 199–202, 1991.
   PubMed Web of Science ®Google Scholar
• Pongracz, K. and Bodell, W.J., Synthesis of N2– (-4–hydroxyphenyl)-2–deoxyguanosine-3’- phosphate: comparison by 32P-postlabeling with the DNA adduct formed in HL-60 cells treated with hydroquinone. Chem. Res. Toxicol. 3, 593–598, 1996.
   Google Scholar
• Porteous, J.W. and Williams, R.T., Studies in detoxication 20. The metabolism of benzene. II. The isolation of phenol, catechol, quinol, and hydroxyquinol from the ehtereal sulfate fraction of the urine of rabbits receiving ben- zene orally. Biochem. J. 44, 56–61, 1949.
   Web of Science ®Google Scholar
• Post, G. and Snyder, R., Effects of enzyme induc- tion on microsomal benzene metabolism. J. Toxicol. Environ. Health 11, 811–825, 1983.
   PubMed Web of Science ®Google Scholar
• Post, G., Snyder, R., and Kalf, G.F., Inhibition of RNA synthesis and interleukin-2 production in lymphocytes in vitro by benzene and its metabolites, hydroquinone and p-benzo- quinone. Toxicol. Lett. 29, 161–167, 1985.
   PubMed Web of Science ®Google Scholar
• Post, G., Snyder, R., and Kalf, G.F., Metabolism of benzene and phenol in macrophages in vitro and the inhibition of RNA synthesis by benzene metabolites. Cell Biol. Toxicol. 2, 231–246, 1986.
   PubMed Web of Science ®Google Scholar
• Punjabi, C.J., Laskin, D.L., Heck, D.E., and Laskin, J.D., Production of nitric oxide by murine bone marrow cells. J. Immunology 149, 2179–2184, 1992.
   PubMed Web of Science ®Google Scholar
• Punjabi, C.T., Laskin, J.D., Hwang, S.M., MacEachern, L., and Laskin, D.L., Enhanced production of nitric oxide by bone marrow cells and increased sensitivity to macrophage colony-stimulating factor (CSF) and granulo- cyte-macrophage CSF after benzene treatment of mice. Blood 83, 3255–3263, 1994.
   PubMed Web of Science ®Google Scholar
• Pyatt, D.W., Stillman, W.S., and Irons, R.D., Hydroquinone. A reactive metabolite of ben- zene, inhibits NF-B in primary human CD4+ T Lymphocytes. Toxicol. Appl. Pharamcol. 149, 178–184, 1998.
   PubMed Web of Science ®Google Scholar
• Quijano, C.A., Moore, D., II, Arthur, D., Feusner, J, Winter, S.S., and Pallavicini, M.G., Cy- togenetically aberrant cells are present in the CD34+CD33–38–19– marrow compartment in children with acute lymphoblastic leukemia. Leukemia 11, 1508–1515, 1997.
   PubMed Web of Science ®Google Scholar
• Ramazzini, B., Diseases of Workers, Hafner Pub- lishing Company (under the auspices of the New York Academy of Medicine), New York, 1964 [Note: originally published in 1713].
   Google Scholar
• Rao, G.S., Hematin catalyzed autooxidation of hydroquinone or 1,2,4–benzenetriol. Chem.- Biol. Interactions 80, 339–347, 1991.
   PubMedGoogle Scholar
• Rao, N.R. and Snyder, R., Oxidative modifica- tions produced in HL-60 cells on exposure to benzene metabolites. J. Appl. Toxicol. 15, 403–408, 1995.
   PubMed Web of Science ®Google Scholar
• Rattner, J.B., Hendzel, M.J., Furbee, C.S., Muller, M.T. and Bazett-Jones, D.P. Topoisomerase II alpha is associated with the mammalian centromere in a cell cycle- and species-specific manner and is required for proper centromere/kinetochore structure. J. Cell. Biol. 134, 1097– 1107, 1996.
   PubMedGoogle Scholar
• Raza, A., Mundle, S., Shetty, V., Alvi, S., Chopra, H., Span, L., Parcharidou, A., Dar, S., Venugopal, P., Borok, R., Gezer, S., Showel, I., Loew, J., Robin, E., Rifkin, S., Alston, D., Hernandez, B., Shah, R., Kaizer, H., Gregory, S. and Preisler, H., A paradigm shift in myelodysplastic syndromes. Leuke- mia 10, 1648–1652, 1996.
   PubMed Web of Science ®Google Scholar
• Reddy, M.V., Blackburn, G.R., Irwin, S.E., Kommineni, C., Mackerer, C.R., and Mehlman, M.A., A method for in vitro cul- ture of rat Zymbal gland: use in mechanistic studies of benzene carcinogenesis in combi- nation with 32P-postlabeling. Environ. Health Perspect. 82, 239–247, 1989.
   PubMed Web of Science ®Google Scholar
• Reddy, M.V., Bleicher, W.T., Blackburn, H.R., and Mackerer, C.R., DNA adduction by phenol, hydroquinone, or benzoquinone in vitro but not in vivo: nuclease P1–enhanced 32P- postlabeling of adducts as labeled nucleo- side biphosphates, dinucleotides and nucleo- side monophosphates. Carcinogenesis 11, 1349–1357, 1990.
   PubMed Web of Science ®Google Scholar
• Reddy, M.V., Schultz, S.C., Blackburn, H.R. and Mackerer, C.R., Lack of DNA adduct for- mation in mice treated with benzene. Mutat. Res. 325, 149–155, 1994.
   PubMed Web of Science ®Google Scholar
• Renz, J.F. and Kalf, G.F., Role for interleukin-1 (IL-1) in benzene-induced hematotoxicity: uninhibition of conversion of pre-IL-1 to mature cytokine in murine macrophages by hydroquinone and prevention of benzene-in- duced hematotoxicity in mice by IL-1. Blood 78, 938–944, 1991.
   PubMed Web of Science ®Google Scholar
• Reynolds, W.F., Rhees, J., Maciejewski, D., Paladine, T., Sieburg, H., Maki, R.A. and Masliah, E., Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer’s disease. Exp. Neurol. 155, 31–41, 1999.
   PubMed Web of Science ®Google Scholar
• Rinsky, R.A., Smith, A.B., Hornung, R., Filoon, T.G., Young, R.J., Okun, A.H., and Landrigan, P., Benzene and Leukemia. An epidemiological risk assessment. New Eng. J. Med. 316, 1044–1050, 1987.
   PubMed Web of Science ®Google Scholar
• Rinsky, R.A., Young, R.J., and Smith, A.B., Leu- kemia in benzene workers. Am. J. Ind. Med. 2, 217–245, 1981.
   PubMedGoogle Scholar
• Rosenthal, G.J. and Snyder, C.A., Modulation of the immune response to Listeria monocytogenes by benzene inhalation. Toxicol. Appl. Pharmacol. 80, 502–510, 1985.
   PubMed Web of Science ®Google Scholar
• Ross, D., Siegal D., Gibson, N.W., Pacheco, D., Thomas, D.J., Reasor, M., and Wierda, D., Activation and deactivation of quinones cata- lyzed by DT-diaphorase. Evidence for bioreductive activation of diaziquone (AZQ) in human tumor cells and detoxification of benzene metabolites in bone marrow stroma. Free Radic. Res. Commun. 8, 373–381, 1990.
   PubMed Web of Science ®Google Scholar
• Rossi, A.M., Guarnieri, C., Rovesti, S., Gobba, F., Ghittori, S., Vivoli, G. and Barale, R. Genetic polymorphisms influence variability in benzene metabolism in hmans. Pharmaco- genetics 9, 445–451, 1999.
   PubMedGoogle Scholar
• Rothman, N., Smith, M.T., Hayes, R.B., Traver, R.D., Hoener, B., Campleman, S., Li, G., Dosemeci, M., Linet, M., Zhang, L., Xi, L., Wacholder, S., Lu, W., Meyer, K.B., Titenko-Holland, N., Stewart, J.T., Yin, S., and Ross, D., Benzene poisoning, a risk fac- tor for hematological malignancy, is associ- ated with the NQO1 609 C —> T mutation and rapid fractional excretion of chloroxzone. Cancer Res. 57, 2839–2842, 1997.
   PubMed Web of Science ®Google Scholar
• Rothman, N., Li, G.-L., Dosemeci, M., Bechtold, W.E., Marti, G.E., Wang, Y.-Z., Linet, M., Xi, L.-Q., Lu, W., Smith, M.T., Titenko-Holland, N., Zhang, L.-P., Blot, W., Yin, S.-N., and Hayes, R.B. Hematotoxicity among Chinese workers heavily exposed to benzene. Amer. J. Ind. Med. 29, 236–246, 1996.
   PubMed Web of Science ®Google Scholar
• Rozen, M., Snyder, C.A., and Albert, R.E., De- pression in B- snf T-lymphocyte mitogen- induced blastogenesis in mice exposed to low concentrations of benzene. Toxicol. Lett. 20, 343–349, 1984.
   PubMed Web of Science ®Google Scholar
• Rushmore, T., Snyder, R., and Kalf, G.F., Cova- lent binding of benzene and its metabolites to DNA in rabbit bone marrow mitochondria in vitro. Chem.-Biol. Interactions. 49, 133–154, 1984.
   PubMed Web of Science ®Google Scholar
• Sabourin, M. and Osheroff, N., Sensitivity of human type II topoisomerases to DNA dam- age: stimulation of enzyme-mediated DNA cleavage by a basic, oxidized and alkylated lesions. Nuc. Acids Res. 28, 1947–1954, 2000.
   PubMedGoogle Scholar
• Sabourin, P.J., Chen B.T., Lucier, G., Birnbaum, L.S., Fisher, E., and Henderson, R.F., Ef- fect of dose on absorption and excretion of [14C]benzene administered orally by inhala- tion in rats and mice. Toxicol. Appl. Pharmacol. 87, (2)325–336, 1987.
   Google Scholar
• Sabourin, P.J., Chen, B.T., Birnbaum, L.S., Lucier, G., and Henderson, R.F., Differ- ences in the metabolism and disposition of inhaled [3H]benzene by F344/N rats and B6C3F1 mice. Toxicol. Appl. Pharmacol. 94, 128–140, 1988.
   PubMed Web of Science ®Google Scholar
• Sabourin, P.J., Muggenburg, B.A., Couch, R.C., Lefler, D., Lucier, G., Birnbaum, L.S., and Henderson, R.F., Metabolism of [14C]benzene by cynomologus monkeys and chimpanzees. Toxicol. Appl. Pharmacol. 114, 277–284, 1992.
   PubMed Web of Science ®Google Scholar
• Saito, F.U., Kocsis, J.J., and Snyder, R., Effect of benzene on hepatic drug metabolism and ul- trastructure. Tox. Appl. Pharmacol. 26, 209–217, 1970.
   Web of Science ®Google Scholar
• Sammett, D., Lee, E.W., Kocsis, J.J., and Snyder, R., Partial hepatectomy reduces both metabo- lism and toxicity of benzene. J. Toxicol. Environ. Health 5, 785–792, 1979.
   PubMed Web of Science ®Google Scholar
• Santesson, C.G., Über chronischeV Toxicol. Appl. Pharmacol. ergiftungen mit Steinkohlenteerbenzin: vier Todesfälle. Arch. Hyg. Berl. 31, 336–376, 1897.
   Google Scholar
• Sasiadek, M., Nonrandom distribution of breakpoints in the karyotypes of workers occupationally exposed to benzene. Environ. Health Perspect. 97, 255–257, 1992.
   PubMed Web of Science ®Google Scholar
• Satherley, K., Souza, L., Neale, M.H., Alexander, R.A., Myatt, N., Foss, A.J., Hungerford,
   Google Scholar
• J.L., Hickson, I.D., and Cree, I.A., Rela- tionship between expression of topoisomerase II isoforms and chemosensitivity in choroid melanoma. J. Pathol. 192, 174–181, 2000.
   PubMedGoogle Scholar
• Savilahti, M., More than 100 cases of benzene intoxication in a shoe factory. Observations on hematological symptoms and course of the process in one year. Arch. Gewerbepath. Gerwerbehyg. 15, 147–157, 1956.
   PubMedGoogle Scholar
• Sawahata, T. and Neal, R.A., Biotransformation of phenol to hydroquinone and catechol by rat liver microsomes. Mol. Pharmacol. 23, 453–460, 1983.
   PubMed Web of Science ®Google Scholar
• Schlosser, M.J. and Kalf, G.F., Metabolic activa- tion of hydroquinone by macrophage peroxi- dase. Chem. Biol. Interact. 72 (1–2), 191–207, 1989.
   Google Scholar
• Schlosser, M.J., Shurina, R.D., and Kalf, G.F., Prostaglandin H synthesis catalyzed oxida- tion of hydroquinone to a sulfhydryl-binding and DNA-damaging metabolite. Chem. Res. Toxicol. 3, 333–339, 1990.
   PubMed Web of Science ®Google Scholar
• Schoenfeld, H.A. and Witz, G., DNA-protein cross- link levels in bone marrow cells of mice treated with benzene or trans,trans-muconaldehyde. J. Toxicol. Environ. Health 56, 379–395, 1999.
   PubMed Web of Science ®Google Scholar
• Schrenk, D. and Bock, K.W., Metabolism of ben- zene in rat hepatocytes. Influence of induces on phenol glucuronidation. Drug. Metab. Dispos. 18, 720–725, 1990.
   PubMed Web of Science ®Google Scholar
• Seaton, M.J., Schlosser, P.M., and Medinsky, M.A., In vitro conjugation of benzene me- tabolites by human liver: potential influence of interindividual variability on benzene tox- icity. Carcinogenesis 16, 1519–1527, 1995.
   PubMed Web of Science ®Google Scholar
• Seaton, M.J., Schlosser, P.M., Bond, J.A., and Medinsky, M.A., Benzene metabolism in human liver microsomes in relation to cyto- chrome P4502E1 activity. Carcinogenesis 15, 1799–1806, 1994.
   PubMed Web of Science ®Google Scholar
• Seaton, M.J., Schlosser, P.M., Bond, J.A., and Medinsky, M.A., Benzene metabolism by human liver microsomes in relation to cyto- chrome P450 2E1 activity. Carcinogenesis 15, 1799– 1806, 1994.
   PubMed Web of Science ®Google Scholar
• Seidel, H.J., Barthel, E., and Zinser, D., The he- matopoietic stem cell compartments in mice during and after long-term inhalation of three doses of benzene. Exp. Hematol. 17, 300– 303, 1989.
   PubMed Web of Science ®Google Scholar
• Selling, L., A preliminary report on some cases of purpura hœmorrhagica due to benzol poison- ing. Johns Hopkins Hosp. Bull. 21, 33–37, 1910.
   Google Scholar
• Selling, L., Benzol as a leucotoxin. Studies on the degeneration of the blood and hœmatopoietic organs. Johns Hopkins Hosp. Rep. 17, 83– 148, 1916.
   Google Scholar
• Simonds, J.P. and Jones, H.M., The effect of injections of benzol upon the production of antibodies. J. Med. Res. 33, 197–209, 1915.
   PubMedGoogle Scholar
• Singh, V., Ahmed, S., and Rao, G.S., Prooxidant and antioxidant properties of iron-hydro- quinone and iron-1,2,4–benzenetriol complex. Implications for benzene toxicity. Toxicology 89, 25– 33, 1994.
   PubMedGoogle Scholar
• Siou, G., Conan, L., and Haitem, M., Evaluation of the clastogenic action of benzene by oral administration with 2 clastogenic techniques in mouse and Chinese hamster. Mt. Res. 90, 273–278, 1981.
   Google Scholar
• Smith, M.K., Trempus, C.S., and Gilmour, S.K., Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces sponta- neous papillomas and malignant conversion in transgenic skin. Carcinogenesis 19, 1409–1415, 1998a.
   PubMedGoogle Scholar
• Smith, M.T. and Fanning, E.W. Report on the workshop entitled: “Modeling chemically in- duced leukemia– implication for benzene risk assessment. Leuk. Res. 21, 361–374, 1997.
   Google Scholar
• Smith, M.T., Zhang, L., Jeng, M., Wang, Y.,
   Google Scholar
• Guo, W., Duramad, P., Hubbard, A.E., Hofstadler, G. and Holland, N.T., Hydro- quinone, a benzene metabolite, increases the level of aneusomy of chromosomes 7 and 8 in human CD34–positive blood progenitor cells. Carcinogenesis 21, 1485–1490, 2000.
   PubMedGoogle Scholar
• Smith, M.T., Zhang, L., Wang, Y., Hayes, R.B., Li, G., Wiemals, J., Dosemeci, M., Titenko- Holland, N., Xi, L., Kolachana, P., Yin, S., and Rothman, N., Increased translocations and aneusomy in chromosomes 8 and 21 among workers exposed to benzene. Cancer Res. 58, 2176–2181, 1998b.
   PubMed Web of Science ®Google Scholar
• Snyder, C.A., Goldstein, B., Sellakumar, A. and Albert, R.E. Toxicity of chronic benzene inhalation: CD-1 mice exposed to 300 ppm. Bull. Environ. Contam. Toxicol. 29, 385–391, 1984.
   Google Scholar
• Snyder, C.A., Goldstein, B., Sellakumar, A.R., Albert, R.E. Evidence for hematotoxicity and tumorigenesis in rats exposed to 100 ppm benzene. Am. J. Ind. Med. 5(6),429–434, 1984.
   Google Scholar
• Snyder, C.A., Goldstein, B., Sellakumar, A., Bromberg, I., Laskin, S., and Albert, R., The inhalation toxicology of benzene inci- dence of hematopoietic neoplasms and hematotoxicity in AKR/J and C57Bl/6J mice. Toxicol. Appl. Pharmacol. 54, 323–331, 1980.
   PubMed Web of Science ®Google Scholar
• Snyder, C.A., Goldstein, B., Sellakumar, A., Bromberg, I., Laskin, S., and Albert, R., Toxicity of chronic benzene inhalation: CD- 1 mice exposed to 300 ppm. Bull. Environ. Contam. Toxicol. 29, 385–391, 1982.
   PubMedGoogle Scholar
• Snyder, C.A., Goldstein, B., Sellakumar, A., Nohnan, S., Bromberg, I., and Laskin, S., Hematotoxicity of inhaled benzene to Sprague-Dawley rats and AKR mice at 300 ppm. J. Toxicol. Environ. Health 4, 605–618, 1978.
   PubMedGoogle Scholar
• Snyder, C.A., Green, J., LoBue, J., Goldstein, B., Valle, C., and Albert, R.E., Protracted ben- zene exposure causes a proliferation of my- eloblasts and/or promyelocytes in CD-1 mice. Bull. Environ. Contam. Toxicol. 27, 17–22, 1981.
   PubMedGoogle Scholar
• Snyder, R., Recent developments in the under- standing of benzene toxicity and leukemo- genesis. Drug Chem. Toxicol. 23, 13–25, 2000.
   PubMed Web of Science ®Google Scholar
• Snyder, R. and Hedli, C.C., An Overview of Ben- zene Metabolism. Environmental Health Per- spectives 104, 1165–1171, 1996.
   PubMed Web of Science ®Google Scholar
• Snyder, R. and Kocsis, J.J. Current concepts of chronic benzene toxicity. CRC Crit. Revs. Toxicol. 3, 265–288, 1975.
   PubMedGoogle Scholar
• Snyder, R., Chepiga, T., Yang, C.S., Platt, K., and Oesch, F., Benzene metabolism by reconstituted cytochromes P450 2B1 and 2E1 and its modulation by cytochrome B5, microsomal epoxide hydrolase, and glu- tathione transferases: evidence for an im- portant role of microsomal epoxide hydro- lase in the formation of hydroquinone. Toxicol. Appl. Pharmacol. 122, 172–181, 1993.
   PubMed Web of Science ®Google Scholar
• Snyder, R., Dimitriadis, E., Guy, R., Hu, P., Cooper, K.R., Bauer, H., Witz, G., and Goldstein, B.D., Studies on the mechanism of benzene toxicity. Environ. Hlth. Perspect. 82, 31–35, 1989.
   PubMed Web of Science ®Google Scholar
• Snyder, R., Jowa, L., Witz, G., Kalf, G.F., and Rushmore, T., Formation of reactive inter- mediates from benzene. Arch. Toxicol. 60, 61–64, 1987.
   PubMed Web of Science ®Google Scholar
• Snyder, R., Lee, E.W., and Kocsis, J.J., Binding of labeled benzene metabolites in mouse liver and bone marrow. Res. Commun. Chem. Pathol. Pharmacol. 20, 191–194, 1978.
   PubMedGoogle Scholar
• Snyder, R., Uzuki, F., Gonasun, L., Bromfeld, E., and Wells, A., The metabolism of ben- zene in vitro. Toxicol. and Appl. Pharmacol. 11, 346–360, 1967.
   Web of Science ®Google Scholar
• Spalding, J.W., French, J.E., Stasiewicz, S., Furedi-Macchacek, M., Conner, F.,Tice, R.R., and Tennant, R.W., Responses of transgenic mouse lines p53+/- and Tg.AC to agents tested in conventional carcinogenicity bioassays. Toxicol. Sci. 53, 213–223, 2000.
   PubMed Web of Science ®Google Scholar
• Spalding, J.W., French, J.E., Tice, R.R., Furedi- Macchacek, M., Hasemaan, J.K., and Tennant, R.W., Development of a transgenic mouse model for carcinogenesis bioassays: evaluation of chemically induced skin tumors in Tg.AC mice. Toxicol. Sci. 49, 241–254, 1999.
   PubMed Web of Science ®Google Scholar
• Stillman, W.S., Varela Garcia, M., and Irons, R.D., The benzene metabolite, hydroquinone, selectively induces 5q31– and -7 in human CD34+CD19– bone marrow cells. Exp. Hematol. 28, 169–176, 2000.
   PubMed Web of Science ®Google Scholar
• Styles, J.A. and Richardson, C.R. Cytogenic ef- fects of benzene: dosimetric studies on rats exposed to benzene vapor. Mut. Res. 135, 203–209, 1984.
   PubMed Web of Science ®Google Scholar
• Subrahmanyam, V.V., Doane-Setzer, P., Steinmetz, K.L., Ross, D., and Smith M.T., Phenol- in- duced stimulation of hydroquinone bioactivation in mouse bone marrow in vivo: possible impli- cations in benzene myelotoxicity. Toxicology 62, 107–116, 1990.
   PubMed Web of Science ®Google Scholar
• Subrahmanyam, V.V., Kolachana, P., and Smith, M.T., Metabolism of hydroquinone by hu- man myeloperoxidase: Mechanisms of stimu- lation by other phenolic compounds. Arch. Biochem. Biophys. 286, 76–84, 1991.
   PubMed Web of Science ®Google Scholar
• Svirbely, J., Dunn, R., and von Oettingen, W., The chronic toxicity of moderate concentra- tion of benzene and of mixtures of benzene and its homologues for rats and dogs. J. Ind. Hyg. Toxicol. 26, 37–46, 1944.
   Google Scholar
• Thielmann, H.W. and Popanda, O., Doxorubicin and gamma rays increase the level of DNA topoisomerase IIalpha in nuclei of normal and xeroderma pigmentosum fibroblasts. J. Can- cer Res. Clin. Oncol. 124, 355–366, 1998.
   PubMedGoogle Scholar
• Thomas, D.J., Sadler, A., Subrahmanyam, V.V., Siegel, D., Reasor, M.J., Weirda, D., and Ross, D., Bone marrow stromal cell bioactivation and detoxification of benzene the metabolite hydro- quinone: comparison of macrophages and fibroblastoid cells. Mol. Pharmacol. 37, 255–262, 1990.
   PubMed Web of Science ®Google Scholar
• Tice, R.R., Costa, D.L., and Drew, R.T., Cytoge- netic effects of inhaled benzene in murine bone marrow: Induction of sister chromatid exchanges, chromosome aberrations, and cel- lular proliferation inhibition in DBA/2 mice. Proc. Natl. Acad. Sci. 77, 2148–2152, 1980.
   PubMed Web of Science ®Google Scholar
• Till, J.E. and McCulloch, A.E., A direct measure of the radiation sensitivity of normal mouse bone marrow cells. Radiation Res. 14, 213– 222, 1961.
   PubMed Web of Science ®Google Scholar
• Tompa, A., Major, J., and Lakab, M.G., Moni- toring of benzene exposed workers for genotoxic effects of benzene: improved-work- ing-condition-related decrease in the frequen- cies of chromosomal aberrations in periph- eral blood lymphocytes. Mutat. Res. 304, 159–165, 1994.
   PubMed Web of Science ®Google Scholar
• Tough, I.M. and Court Brown, W.M., Chromo- some aberrations and exposure to ambient benzene. Lancet i, 684–685, 1965.
   Google Scholar
• Tough, I.M., Smith, P.G., Court Brown, W.M., and Harnden, D.G., Chromosome studies on workers exposed to atmospheric benzene. Europ. J. Cancer 6, 49–55, 1970.
   PubMed Web of Science ®Google Scholar
• Trempus, C.S., Ward, S., Farris, G., Malarkey, D., Faircloth, R.S., Cannon, R.E., and Mahler, J.F., Association of v-Ha-ras transgene expression with development of erythroleukemia in Tg.AC transgenic mice. Am. J. Pathology 153, 247–254, 1998.
   PubMedGoogle Scholar
• Tricot, G.J.K., The myelodysplastic syndromes, in Hematology: Basic Principles and Practice. Hoffman, R., Benz, E.J., Jr, Shattil, S.J., Furie, B., and Cohen, H.J., Eds., Churchill Livingstone, New York, 1991, 805–817.
   Google Scholar
• Troester, M.A., Waidyanatha, S., and Rappaport, S.M., Stability of hemoglobin and albumin adducts of benzene oxide and 1,4,-benzo- quinone after administration to F344 rats. Toxicol. Sci. 54, 88–94, 2000.
   PubMed Web of Science ®Google Scholar
• Tsutsui, T., Hayashi, N., Maizumi, H., Huff, J., and Barrett, J.C., Benzene-,catechol hydro- quinone- and phenol-induced cell transforma- tion, gene mutations, chromosomes aberrations. Aneuploidy, sister chromatid exchanges and unscheduled DNA synthesis in Syrianhamster embryo cells. Mut. Res. 373, 113–123, 1997.
   PubMed Web of Science ®Google Scholar
• Tunek, A., Platt, K.L., Bentley, P., and Oesch, F., Microsomal metabolism of benzene to species irreversibly binding to microsomal protein and effects of modifications of this metabolism. Mol. Pharmacol. 14, 920–929, 1978.
   PubMed Web of Science ®Google Scholar
• Tunek, A., Platt, K.L., Przybylski, M., and Oesch, F., Multi-step metabolic activation of ben- zene. Effect of superoxide dismutase on co- valent binding to microsomal macromolecules, and identification of glutathione conjugates using high pressure liquid chromatography and field desorption mass spectrometry. Chem.-Biol. Interactions 33, 1–17, 1980.
   PubMed Web of Science ®Google Scholar
• Turkel, B. and Egli, U., Analysis of chromosomal aberrations in shoe workers exposed long term to benzene. Occup. Environ. Med. 51, 50–53, 1994.
   PubMed Web of Science ®Google Scholar
• Utterbach, D.F, and Rinsky, R.A., Benzene expo- sure assessment in rubber hydrochloride work- ers: a critical evaluation of previous estimates. Am. J. Ind. Med., 27, 661–667, 1995.
   PubMedGoogle Scholar
• Uyeki, E.M., Askar, A.E., Shoeman, D., and Bisel, T.U., Acute toxicity of benzene inhalation to hematopoietic precursor cells. Toxicol. Appl. Pharmacol. 40, 49–57, 1977.
   PubMed Web of Science ®Google Scholar
• Valentine, J.L., Lee, S.S.-T., Seaton, M.J., Asggharian, B., Farris, G., Corton, J.C., Gonzalez, F.J. and Medinsky, M.A., Re- duction of benzene metabolism and toxicity in mice that lack CYP2E1. Toxicol. Appl. Pharmacol. 141, 205–213, 1996.
   PubMed Web of Science ®Google Scholar
• Van den Berghe, H., Louwagie, A., Broeckaert-Van Orshoven, A., David, G., and Verwilghen, R., Chromosome analysis in two unusual malignant blood disorders presumably induced by benzene. Blood 53, 558–566, 1979.
   PubMed Web of Science ®Google Scholar
• Vigliani, E.C. and Forni, A., Benzene and leuke- mia. Environ. Res. 11, 122–127, 1976.
   PubMed Web of Science ®Google Scholar
• Vigliani, E.C. and Forni, A., Benzene, chromo- some changes and leukemia. Letter to the Editor, J. Occup. Med. 11, 148–149, 1969.
   PubMedGoogle Scholar
• Vigliani, E.C. and Saita, G., Benzene and leuke- mia. N. Eng. J. Med., 271, 872–876, 1964.
   PubMed Web of Science ®Google Scholar
• Wallace, L.A., Major sources of benzene exposure. Environ. Health Perspect. 82, 165–169, 1989.
   PubMed Web of Science ®Google Scholar
• Wang, H., Mao, Y., Chen, A.Y., Zhou, N., LaVoie, E.J. and Liu, L.F., Biochemistry 40, 3316– 3323, 2001
   Google Scholar
• Ward, J.M., Weisberger, J.H., Rammamoto, S., Benjamin, T., Brown, C.A., and Weisberger, E.K., Long-term effect of benzene in C57BL.6N mice. Arch. Environ. Health 30, 22–25, 1975.
   PubMed Web of Science ®Google Scholar
• Weiskotten, H.G., Wyatt, T.C., and Gibbs, R.F.D.,The action of benzol.VI. Benzol va- por leucopenia (rabbit). J. Med. Res. 41, 425– 438, 1920.
   PubMedGoogle Scholar
• Weiss, L. The hematopoietic microenvironment of the bone marrow: an ultrastructural study of the stroma in rats. Anat. Rec. 186, 161–184, 1976.
   PubMedGoogle Scholar
• White, W.C. and Gammon, A.M., The influence of benzol inhalations on experimental tuber- culosis in rabbits. Trans. Assoc. Amer. Phy. 29, 332, 1914.
   Google Scholar
• Whysner, J. Benzene-induced genotoxicity. J. Toxicol. Environ. Health. Part A. 61, 347– 351.
   Google Scholar
• Wierda, D. and Irons, R., Hydroquinone and cat- echol reduce the frequency of progenitor B lymphocytes in mouse spleen and bone mar- row. Immunopharmacology 4, 41–54, 1982.
   PubMed Web of Science ®Google Scholar
• Wierda, D., Irons, R., and Greenlee, W., Immunotoxicity in C57Bl/6 mice exposed to benzene and arochlor 1254. Toxicol. Appl. Pharmacol. 60, 410–417, 1981.
   PubMed Web of Science ®Google Scholar
• Williams, R.T., Detoxication Mechanisms. John Wiley and Sons, Inc., New York, 189–191, 1959a.
   Google Scholar
• Williams, R.T., Detoxication Mechanisms. John Wiley and Sons, Inc., New York, 109, 192, 1959b.
   Google Scholar
• Winterbourn, C.C., Vissers, M.C., and Kettle, A.J., Myeloperoxidase. Curr. Opon. Hematol. 7, 53–58, 2000.
   PubMed Web of Science ®Google Scholar
• Witz, G., Maniara, W., Mylavarapu, V., and Goldstein, B.D., Comparative metabolism of benzene and trans,trans-muconaldehyde to trans,trans-muconic acid in DBA/2N and C57Bl/6 mice. Biochem. Pharmacol. 40, 1275–1280, 1990.
   PubMedGoogle Scholar
• Witz, G., Zhang, Z. and Goldstein, B.D. Reactive ring-opened aldehyde metabolites in benzene hematotoxicity. Environmental Health Per- spectives 104, 1195–1199, 1996.
   PubMed Web of Science ®Google Scholar
• Wolf, M., Rowe, V., McCollister, D., Hollingsworth, R., and Oyen, F., Toxicological studies of cer- tain alkylated benzenes and benzene. AMA Arch. Ind. Health 14, 387–398, 1956.
   PubMedGoogle Scholar
• Xie, D., Hoffmann, W.K., Mori, N., Miller, C.W., Hoelzer, D., and Koeffler, H.P., Allelotype analysis of the myelodysplastic syndrome. Leukemia 14, 805–810, 2000.
   PubMed Web of Science ®Google Scholar
• Yeowell-O’Connor, K., Rothman, N., Smith, M.T., Hayes, R.B., Waidyanatha, S., Dosemeci, M., Zhang, L., Yin, S., Titenko- Holland, N. and Rappaport, S.M., Hemo- globin and albumin adducts of benzene oxide among workers exposed to high levels of benzene. Carcinogenesis 19, 1565–1571, 1998.
   PubMedGoogle Scholar
• Li, Q, Liu, Y., Tian, F., Du, C. and Jin, C. Occupational exposure to benzene in China. Brit. J. Ind. Med. 44, 192–195, 1987.
   PubMedGoogle Scholar
• Yin, S.-N., Li, G.-L., Tain, F.-D., Fu, Z.-I., Jin, C., Chen, Y.-J., Luo, S.-J., Ye, P.-Z., Wang, G.- C., Zhang, X.-C., Wu, H.-N., and Zhong, Q.-C. A retrospective chort study of leuke- mia and other cancers in benzene workers. Environ. Health Perspect. 82, 207–213, 1989.
   PubMed Web of Science ®Google Scholar
• Yin, S.-N, Hayes, R.B., Linet, M.S., Li, G.-L., Dosemeci, M., Travis, L.B., Zhang, Z.-N., Li, D.-G., Chow, W.-H., Wacholder, S., Blot, W.J. and The Benzene Study Group. An expanded cohort study of cancer among benzene-exposed workers in China. Environ. Health Perspect. 104 (Suppl. 6), 1339–1341,1996.
   Google Scholar
• Young, N.S. and Maciejewski, J.P. Aplastic ane- mia, in Hematology, 3nd ed., Hoffman, R., Benz, E.J. , Shattil, S.J., Furie, B., Cohen, H.J., Silberstein, L.E., and McGlace, P. Eds., Churchill Livingstone, New York, 2000, Chapter 19, 314–315.
   Google Scholar
• Zhang, L., Robertson, M.L., Kolachana, P., Davidson, A.J., and Smith, M.T., Benzene etabolite, 1,2,4–benzenetriol, induced micro- nuclei and oxidative DNA damage in human lymphocytes and HL60 cells. Environ. Mol. Mutagen. 21, 339–348, 1993.
   PubMedGoogle Scholar
• Zhang, L., Rothman, N., Wang, Y., Hayes, R.B., Li, G., Dosemeci, M., Yin, S., Kolachana, P., Titenko-Holland, N., and Smith, M.T., Increased aneusomy and long arm deletion of chromosomes 5 and 7 in the lymphocytes of Chinese workers exposed to benzene. Car- cinogenesis 19,1955–1961, 1998.
   PubMed Web of Science ®Google Scholar
• Zhang, Z., Goldstein, B.D., and Witz, G., Iron- stimulated ring opening of benzene in a mouse liver microsome system. Biochem. Pharmacol. 50, 1607–1617, 1995b.
   PubMedGoogle Scholar
• Zhang, Z., Kline, S.A., Kirley, T.A., Goldstein, B.D., and Witz, G., Pathways of trans,trans muconaldehyde metabolism in mouse liver cytosol: reversibility of nonreductive metabo- lism and formation of end products. Mut. Res. 67, 461–467, 1993.
   Google Scholar
• Zhang, Z., Xiang, Q., Platt, K.L., Goldstein, B.D., and Witz, G., Studies on pathways of ring opening of benzene in a Fenton system. Free Radic. Biol. Med. 18, 411–419, 1995a
   PubMedGoogle Scholar